AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW 8,530.00
+350.00 (4.28%)
Oct 11, 2024, 9:00 AM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 206.74 billion as of October 11, 2024. Its market cap has decreased by -17.73% in one year.
Market Cap
206.74B
Enterprise Value
174.14B
Revenue
2.06B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,530.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 206.74B, a decrease of -51.16%. That is a compound annual growth rate of -12.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 210.95B | 4.53% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | 563.64B | 49.70% |
| Dec 30, 2019 | 376.51B | -11.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition